Amarin Corp Plc (AMRN)

[rosemountbomber]

Sleven, JRoon, a good example of the new FDA standards and thinking was their approval of lecanemab earlier this year:

https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment

Lecanemab trial was considerably larger than BRAVE-EPA, was done on subjects with mild AD vs cognitively healthy subjects in BRAVE-EPA. IMHO, positive results in BRAVE-EPA would be greeted with calls for a larger study but would still boost stock price and would definitely spike interest with the BP community.